Novo-Backed MapLight Raises $258.9 Million in US IPO, Placement
PositiveFinancial Markets

MapLight Therapeutics Inc. has successfully raised $258.9 million through its initial public offering and private placement, marking a significant milestone as the first company to go public using this unique approach since the US government shutdown. This move not only highlights the resilience of the biotech sector but also signals investor confidence in innovative companies, making it a noteworthy event in the financial landscape.
— Curated by the World Pulse Now AI Editorial System









